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Available online 12 August 2013Abstract Although the mammalian target of rapamycin complex 1 (mTORC1) functions as an important signaling complex in
many cellular processes, the role of mTORC1 in neurons derived from embryonic stem cells (ESCs) has been less explored. Here,
using a modified protocol to differentiate mouse ESCs (mESCs) into almost uniform glutamatergic neurons, we explored the
importance of raptor/mTORC1 in the differentiation of mESCs. Raptor gene-trap mESCs, and raptor-knockdown mESCs formed
smaller-sized embryonic bodies than the wild type and failed to undergo neuronal differentiation. Treatment with 1 μM
rapamycin starting at the point when neuronal precursors began to differentiate from mESCs caused the gradual loss of
neurites, shrinkage of soma, and a decreased ratio of neurite length to cell number over 48 to 72 h of treatment. This change
was accompanied by activation of caspase-3 and S6 kinase (S6K), but not 4E-binding protein 1 (4EBP1). Knockdown of raptor
during neuronal differentiation from mESCs also resulted in gradual loss of neurites and shrinkage of cell bodies. Loss of neurite
density resulting from rapamycin treatment could be reversed by overexpression of S6K T389E. Taken together, these data
demonstrate that raptor/mTORC1/S6K plays a critical role in the differentiation and survival of neurons derived from mESCs.
© 2013 Elsevier B.V. All rights reserved.Introduction
In recent years, considerable research efforts have been
directed towards the generation of neurons from human and
mouse embryonic stem cells (ESCs). Examples include motor
neurons (Chipman et al., 2012), dopaminergic neurons (Kriks
et al., 2011), GABAergic cerebral cortical interneurons
(Goulburn et al., 2012) and glutamatergic neurons (Bibel
et al., 2004; Chuang et al., 2011; Hubbard et al., 2012). Because
of their physiological relevance and potential applications, in⁎ Corresponding author at: Department of Life Science, National Taiwan
ROC. Fax: +886 2 29312904.
E-mail address: yenshoulin@ntnu.edu.tw (Y. Lin).
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http://dx.doi.org/10.1016/j.scr.2013.08.003addition to cell lines or primary neurons, neuronal cells derived
from ESCs have gradually emerged as one focus (Ban et al.,
2007; Erceg et al., 2009). Currently, however, two obstacles still
hinder the application of the in vitro ESC model in translational
medicine. First, differentiation protocols result in the simulta-
neous production of heterogeneous cell populations, thus
constraining studies on selected subsets of cells; and second,
relatively little is known about differentiation pathways in
culture and how these pathways compare with those in
developing embryos (Wobus and Boheler, 2005).Normal University, 88, Ting-Chou Road, Section 4, Taipei 116, Taiwan,
1118 J.-H. Chuang et al.The serine–threonine protein kinase, mammalian target
of rapamycin (mTOR) is a central regulator of many cellular
processes including growth, survival, metabolism, and many
diseases (Dazert and Hall, 2011). In mammalian cells, mTOR
forms complexes, termed mTOR complex 1 (mTORC1) and 2
(mTORC2). mTORC1 consists of mTOR, mLST8, DEPTOR,
PRAS40, and raptor. It controls the translation by directly
phosphorylating the downstream S6 kinase (S6K) at the
Thr389 residue and eukaryotic initiation factor 4E-binding
protein 1 (4EBP1) at the Thr37/46 residues. mTORC2 consists
of mTOR, mLST8, DEPTOR, PROTOR, mSin1, and rictor. It
phosphorylates Akt, PKCα and SGK1, and regulates actin
dynamics (for reviews see (Appenzeller-Herzog and Hall,
2012; Laplante and Sabatini, 2012)). Knockout of mTOR gene
in mice resulted in embryonic lethality (Murakami et al.,
2004). Like mice null for mTOR, embryos lacking mLST8 and
rictor die around E10.5 (Guertin et al., 2006). In the same
study, raptor-deficient embryos were also found to die early
in development. The role of raptor/mTORC1 in neurons
differentiated from mouse ESCs (mESCs) is unknown.
Several studies using cell lines or primary cells have
reported that mTOR plays a role in neuronal growth. mTOR
contributes to increases in filopodia/spine number (Kumar
et al., 2005; Tavazoie et al., 2005), dendritic arbor formation
(Jaworski et al., 2005), long-lasting long-term potentiation
(L-LTP), long-term depression (LTD) (Hou and Klann, 2004;
Tang et al., 2002), and synaptic transmission (Weston et al.,
2012). Although there is a substantial body of literature on
mTOR and neurons, the vast majority of studies used cell lines
and/or primary neurons. In this study, we characterized
a previously established, almost uniform population of
glutamatergic neurons differentiated from mESCs. Using
both pharmaceutical and molecular approaches, we sys-
tematically explored the importance of raptor/mTORC1 in
neurons differentiated from mESCs. We found that neuro-
genesis from mESCs, as analyzed in a predominantly
glutamatergic population, requires raptor/S6K signaling.Materials and methods
Reagents
Antibodies included type III beta-tubulin, synaptotagmin,
AMPA receptor (AMPAR) (Abcam, Cambridge, UK), PSD-95,
Oct4 (BD Falcon, Franklin Lakes, NJ, USA), MAP2 (Millipore,
Billerica, MA, USA); vGLUT1/2 (SYSY, Gottingen, Germany),
Akt Thr308, S6K Thr389, 4EBP1 Thr37/46, p44/42 MAPK, p44/
42 MAPK Thr202/Tyr204, cleaved caspase-3 Asp175 (Cell
Signaling Technology, Danvers, MA, USA), pro-caspase-3, S6K
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), Akt, Akt
Ser473, 4EBP1, 4EBP1 Thr37, S6, S6 Ser235/236 (Epitomics,
Burlingame, CA, USA), and horseradish peroxidase (HRP)
anti-rabbit and anti-mouse secondary antibodies (Jackson,
West Grove, PA, USA). Dulbecco's modified Eagle's medium/
F12 (DMEM/F12), N2 supplement, Neurobasal medium, B27
supplement, Neurobasal A medium, and geneticin/G418 were
obtained from Invitrogen/Gibco (Grand Island, NY, USA). Fetal
bovine serum (FBS) was from Thermo Scientific/Hyclone
(Logan, UT, USA). All other chemicals came from Sigma
(St. Louis, MO, USA) unless indicated.Feeder-independent mESC culture, embryoid body
dissociation, and neuronal differentiationThe mESC clone ES-E14TG2a was purchased from American
Type Culture Collection and cultivated in a feeder-
independent pattern by which the culture plates were
coated with 0.1% gelatin for at least 30 min before seeding
mESCs onto them. The methodology was originally based on
the protocol of Bibel et al. (2004). They developed the
method and reported that essentially all neurons were
positive for glutamate vesicular transporter 1. After 1–
3 weeks in culture, the synaptic activity observed in their
cultures can be accounted for by the action of majority
glutamate and minor GABA (5%) on postsynaptic cells.
Initially, after all of the procedures were deliberately
repeated, we found that a homogeneous population was
still not always obtained (Chuang et al., 2011). After many
attempts, we modified some procedures and found that it
is crucial to dissociate the embryoid bodies (EBs) with
appropriate timing rather than completely trypsinize EBs.
Eventually, we consistently established almost completely
uniform neurons derived from mESCs in our laboratory.
Therefore, the cultivated mESC medium contained Glasgow
Minimum Essential Medium (GMEM; Sigma) supplemented
with 0.05 mM β-mercaptoethanol, 2 mM L-glutamine, 1 mM
sodium pyruvate, 1× non-essential amino acids, 10% fetal
bovine serum (FBS), and 500–1000 U leukemia inhibitory
factor (LIF; Millipore ESGRO). As the confluency of cell
growth reached 90%–95%, cells were split using trypsin/
EDTA and continually cultivated in a 37 °C, 5% CO2 incubator
to maintain the mESCs. The procedures used for EB
dissociation and neuronal differentiation, as well as partial
characterization of neurons, have been described previously
(Chuang et al., 2011; Lin, 2012). Briefly, we cultivated
mESCs in 10-cm bacterial dishes containing mESC medium
but no LIF. The mESCs gradually proliferated and aggregated
to form spherical shapes called embryonic bodies (EBs). The
medium was changed every two days by passing cells through
a 40-μm nylon cell strainer and placing them in a new
bacterial dish. To initiate neuronal differentiation, we
directly added a final concentration of 5 μM all-trans
retinoic acid to the medium on day 4 after EB formation
started. Four more days later, EBs were dissociated for
around 8 to 10 min in a trypsinization buffer, which was
freshly prepared from 0.05% powdered trypsin and 0.02%
EDTA dissolved in a phosphate buffered saline (PBS) solution.
To collect cells, the mixture was gently pipetted up and
down and centrifuged for 5 min at 1000 rpm at room
temperature. The pellet in the tube was resuspended in N2
medium (DMEM/F12 supplemented with 8.6 mM glucose,
0.5 mM L-glutamine, 20 mM NaHCO3, and 1× N2 supple-
ment) and filtered through a 40-μm cell strainer. An optimal
cell density of around 1.35 × 105/cm2 was determined and
seeded onto poly-DL-ornithine/laminin-coated plates. The
medium was changed to fresh N2 medium at 2 and 24 h after
plating. At 48 h after plating, we changed the N2 medium to
Neurobasal-B27 medium (Neurobasal medium supplemented
with 0.5 mM L-glutamine and 1× B27 supplement). Thereaf-
ter, the Neurobasal-B27 medium was partially replaced with
fresh medium every other day to maintain the neuronal
culture.
1119Raptor in neurons derived from mESCsRaptor gene trap mESC clone selection, three-primer
PCR, and Southern blot
We obtained the raptor gene trap mESC clone RRO611
containing pGT2Lxf gene trap vector (~8.6 kb) integrated
into the intron sequence (~51 kb) between exon 1 and exon 2
of the raptor gene from BayGenomics/Mutant Mouse Regional
Resource Center (MMRRC, San Francisco, CA, USA), a product
of the International Gene Trap Consortium. This clone was
from mouse strain 129/Ola and its parental mESCs were the
E14TG2a clone. To obtain the homozygote raptor gene trap
clone, we applied geneticin 1.75–2.25 mg/ml to the culture
of RRO611 mESCs. After drug selection for 9 to 12 days, we
selected several clones grown from a single cell and verified
them by three-primer PCR. We mapped the insertion site of
the trapping vector pGT2Lxf around 31 kb downstream of
exon 1 on the raptor gene. Based on this, the primers designed
to verify the genotype were forward primer 5′GAAGAGGT
CACAATGTCC within the intron, reverse primer 5′CACTCC
AACCTCCGCAAACTC within the trapping vector, and another
reverse primer 5′CCTAGATCCAGCCAAAGA within the intron,
by which a PCR with short extension time will produce around
800 and 1400 base pair fragments if the genotype is
heterozygote. For Southern blot analysis, mESC genomic DNA
was lyzed in a buffer that contained 10 mM Tris–HCl pH 7.5,
10 mM EDTA, 10 mMNaCl, 0.5% (w/v) N-Lauroylsarcosine, and
1 mg/ml proteinase K. After phenol/chloroform extraction,
5 M NaCl precipitation, and ice-cold ethanol purification, the
DNA was subjected to restriction enzyme BamHI digestion, run
onto agarose gel, and transferred to nitrocellulose paper. A
DNA fragment of around 570 base pairs was originally
generated by PCR with forward primer 5′ATCCTGGCTACTT
GGGCCTCCAGT and reverse primer 5′CTGTGCAAACAGCCCA
AGTTCCTG. This was further used as a template to obtain a
single strand probe with radioisotope labeling, by performing
PCR containing single primers, dATP, dTTP, dGTP and 32P
dCTP. The outcome shows two bands with 6200 and 4500 base
pairs if the genotype is heterozygote.Primary cortical neurons cultured from mice
In the experiments using primary cortical neurons as a positive
control, cerebral cortexes were dissociated from BALB/c mice
on postnatal day 2 (P2). The protocol was adopted from Brewer
and Torricelli (2007) with modifications. Briefly, about 85 mg
of dissociated cortex tissue was maintained temporarily in cold
Neurobasal A medium. We transferred cell pieces to a tube for
papain digestion by shaking for 20 min. The residues after
gravity precipitation were incubated in fresh Neurobasal A
medium followed by gentle pipetting for 45 s, then set still for
2 min precipitation. This step of dissociating residues was
repeated three times, and each time the supernatants were
collected into a new tube. The cells collected were carefully
laid onto a prepared OptiPrep gradient tube according to the
method outlined by Brewer and Torricelli (2007). The upper
layers were aspired out after centrifuging at 2000 rpm for
15 min and the lower layers containing neuronal cells were
removed to a new tube containing 5 ml fresh Neurobasal A
medium.We cleaned up these neuronal cells twomore times to
get rid of gradient medium by adding fresh Neurobasal A
medium and centrifuging at 1250 rpm for 5 min. They wereplated onto poly-D-lysine coated culture dishes at a density of
1.04 × 105/cm2. The medium was subsequently changed every
three days using Neurobasal A medium.
Immunocytochemistry of neuronal cells and neurite
density analysis
Differentiated neurons were seeded on glass coverslips
coated with poly-DL-ornithine/laminin or poly-D-lysine/
laminin (Roche, Mannheim, Germany). At a given time
after differentiation, cells were washed with PBS, fixed in 4%
paraformaldehyde prepared in PBS for 30 min, and perme-
abilized in 0.3% Triton X100 in PBS for 10 min. The sample was
further blocked in 1% bovine serum albuminmade in PBS for 1 h
at room temperature. A corresponding primary antibody was
added for 2 h, followed by washing with PBS. A secondary
antibody such as Alexa 488-conjugated anti-mouse (Invitrogen),
Alexa 488-conjugated anti-rabbit (Invitrogen), DyLight 549-
conjugated anti-rabbit IgG (Invitrogen), or rhodamine-
conjugated anti-mouse (Jackson ImmunoResearch, West
Grove, PA, USA) was incubated for 45 min followed by a
PBS wash. Nuclei of cells were stained with 4′, 6′-diamidino-
2-phenyindole (DAPI) for an additional 15 min, followed by
another PBS wash. The coverslip was then mounted on a
glass slide using Fluoromount G (Southern Biotech, Birming-
ham, AL, USA). Images were collected using a Leica SP2
confocal microscope connected to a CCD camera (Leica,
Wetzlar, Germany) or using a Zeiss Axio Observer D1
microscope (Carl Zeiss, Jena, Germany). We defined density
of neurites as neurite length divided by neuron number
measured by Metamorph software or Image-Pro Plus
software. The images were usually taken as three different
fields in each experiment, which was repeated three to four
times. Therefore, a total of around 9 to 12 images were
captured. Each image typically contained more than 50
counted neurons, so a total of around 500 neurons were
evaluated. Figures were prepared using Adobe software.
Construction of overexpression plasmids and RNAi
viral particle preparation
In order tomake proteins that overexpress inmESCs or neurons
differentiated from mESCs, we replaced the U6 promoter in
the pLKO.1 puromycin construct with cytomegalovirus (CMV)
promoter, a constitutive promoter. S6K WT or a constitutive
active form, S6K T389E, was engineered to fuse with green
fluorescent protein (GFP) in the plasmid. By taking advantage
of the pLKO.1 backbone, the infection rate, selection, and
preparation of viruses will be the same as the one using RNAi.
For RNAi viral particle preparation, bacterial clones or
plasmids containing short hairpin RNA oligonucleotides of the
target genes were obtained from the National RNAi Core
Facility (Genomic Research Center, Academia Sinica, Taipei,
Taiwan). Functional clones and corresponding effective target
sequences of control, raptor, and rictor were verified and are
listed below: luciferase (control), 5′CGCTGAGTACTTCGAA
ATGTC, raptor sequence, 5′CCTCATCGTCAAGTCCTTCAA, and
rictor sequence, 5′GCCAGTAAGATGGGAATCATT. RNAi plas-
mids were co-transfected with two other viral packaging
plasmids, pCMV8.91 and pMD.G, into HEK 293T cells. The
virus-containing medium was collected after transfection for
1120 J.-H. Chuang et al.40 h and concentrated by ultracentrifugation at 25,000 rpm
for 2 h. Pellets were concentrated and stored at −80 °C until
use. We followed a protocol provided by the RNAi Core Facility
in Academia Sinica, Taipei, Taiwan to measure the RNAi titer
(http://rnai.genmed.sinica.edu.tw/file/protocol/
4_1_EstimationLentivirusTiterRIUV1.pdf). To test the virus
titer, we also modified this protocol using primary culture of
mice cortical neurons, a cellular model that is much more
sensitive to virus infection, instead of using A549 cells.
Cell lysate and immunoblot assay
Cells used for the immunoblot assays were processed as
previously described (Lin et al., 2002). Briefly, one 3.5-cm
dish of frozen cells was scraped into 0.1 ml of lysis buffer
(50 mM Tris base, pH 7.9, 50 mM NaCl, 0.1 mM EDTA, 20 mM
β-glycerophosphate, 1 mM dithiothreitol, 1 mM phenyl-
methylsulfonyl fluoride, 25 nM calyculin A, 0.5% Triton
X-100, 1 tablet/50 ml of protease inhibitor (Roche)). When
processing EB lysate, EBs were collected at 1000 rpm
centrifuge for 5 min, lysed in lysis buffer, and transferred
into a 2 ml Dounce homogenizer and homogenized with 25–
35 strokes. Lysates were centrifuged at 13,500 rpm for
10 min. Aliquots of the supernatants containing equal
amounts of protein were measured by Bradford assay
(Bio-Rad). For low-molecular-weight proteins such as 4EBP1,
cell lysates were prepared as described above and subjected
to tricine sodium dodecylsulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) according to Schagger's (2006) method.
Briefly, the separation gel contained an additional 0.1%
glycerol in a regular format. The cathode buffer (0.1 M Tris,
0.1 M Tricine, and 0.1% SDS; pH 8.25) and anode buffer (0.1 M
Tris and 0.0225 M HCl; pH 8.9) were loaded onto a gel
apparatus, separated, and transferred. Blots were visualized
using a horseradish peroxide (HRP)-conjugated secondary
antibody followed by chemiluminescence as outlined by
the manufacturer (Thermo Scientific/Pierce, Rockford, IL,
USA).
Statistical analysis
Data are presented as the mean ± SE. Treatment effects
were evaluated using a two-tailed Student's t-test. A P value
of less than 0.05 was considered statistically significant.
Results
Characterization of mESCs derived neurons
We followed the basic protocol with caution to appropri-
ately dissociate EBs rather than completely trypsinized EBs
(Supplemental Fig. S1). Almost completely uniform neurons
were derived from mESCs. The neuron type was confirmed
by immunostaining with a vesicular glutamate transporter
(vGLUT1/2) antibody, a marker of glutamatergic neurons
(Fig. 1A). More than 86% of cells were stained with both
vGLUT1/2 and DAPI. Also, neurons/neurites were confirmed
by staining with class III β-tubulin (red), a neuronal marker,
as shown in Fig. 1B. Within the same field, synaptotagmin
(green), which functions as a calcium sensor in the regulationof neurotransmitter release, also stained these neurons
seven days after differentiation. We further verified the
neurons by western blot analysis. As shown in Fig. 1C, AMPA
receptor (AMPAR), an ionotropic transmembrane receptor
for glutamate in the central nervous system, began to be
expressed on day 3 after differentiation, and was expressed
at a higher level on day 7. PSD-95, a protein that is almost
exclusively located in the post synaptic density of neurons
and is involved in anchoring synaptic proteins, was also
expressed with a similar temporal pattern to AMPAR and
synaptotagmin. The lysates from HEK 293T cells and primary
neuronal cultures of mice cerebral cortex functioned as
negative and positive controls, respectively, for all the
antibodies used. Within the same blot, Oct-4 and type III
β-tubulin, which are markers of mESCs, and differentiated
neurons, respectively, demonstrated that mESCs were
properly maintained and neurons were well developed,
and also indicated that synapses could potentially be
constructed within these neurons.
Raptor gene-trap mESCs exhibited stunted growth
and formation of EBs
We next examined the loss-of-function effect of raptor
knockout on mESCs and neuronal differentiation. Homozy-
gous mESC clones were selected from heterozygous clones
using a high dose of geneticin/G418 2.25 mg/ml. The
genetic composition of these clones was verified. As shown
in Fig. 2A, both three-primer PCR and Southern blot
confirmed that homozygote clones were produced. Howev-
er, trace amounts of protein were still detectable in western
blot analysis, as loading more total lysate (Fig. 2B). We also
performed raptor immunoprecipitation within these clones
and sent them for MS-SPEC analysis (data not shown). The
results showed that there was indeed residue of raptor
protein. Therefore, the EB formation that resulted from
these mESCs was smaller than that from wild type (Fig. 2C).
We further characterized the alteration of signaling mole-
cule phosphorylation in these clones. As shown in Fig. 2D,
phosphorylation of S6K Thr389 still responded to insulin-like
growth factor 1 (IGF-1) stimulation, while the raptor gene
trap mESCs showed trace raptor expression. Among the
signaling surveys, phosphorylation of MAPK, but not Akt,
showed the most significant change with serum withdrawal
and the re-addition of IGF-1.
Knockdown of raptor in mESCs by raptor RNAi also
retarded EB formation
Above we demonstrated that homozygote mESCs derived
from raptor gene-trap formed EBs were smaller than the
wild type and often resulted in unsuccessful neuronal
differentiation. To study the role of raptor in neurons
differentiated from mESCs from a different perspective,
we next established raptor knockdown mESCs using raptor
RNAi infection, followed by puromycin selection. Rictor RNAi
was used as an additional control for comparison. We
verified that raptor and rictor protein levels and phosphor-
ylation of the corresponding downstream signaling mole-
cules such as S6K Thr389 and Akt Ser473 were decreased in
knockdown mESCs (Fig. 3A). The phosphorylation of 4EBP1
Figure 1 Almost uniform neurons differentiated from mESCs show glutamatergic, pre-, and post-synapse markers. A. Neurons
differentiated for 5 days were fixed and immunocytochemistry was performed using vGLUT1/2 as the primary antibody, and Alexa
488-conjugated anti-rabbit immunoglobulin G (IgG) as the secondary antibody. A merged image of vGLUT1/2 (green) and nuclear
staining DAPI (blue) is shown. Scale bar, 40 μm. B. Seven days after neurons differentiated from mESCs in another experiment were
blotted, with class III β-tubulin (red) and synaptotagmin (green) as the primary antibodies and DyLight 549-conjugated anti-rabbit IgG
and Alexa 488-conjugated anti-mouse IgG as the secondary antibodies. The same field was stained with DAPI (blue). Scale bar, 20 μm.
C. Lysates from neurons 3 and 7 days after differentiation from mESCs, along with controls including undifferentiated mESCs, primary
neuronal culture of mice cerebral cortexes, and HEK293T were run onto the gel and blotted with antibodies that contained AMPAR,
synaptotagmin, PSD-95, Oct4, class III β-tubulin, and actin. These photos and blots are representative of one experiment that was
repeated three times.
1121Raptor in neurons derived from mESCsThr37/46 was not examined at this point as decreased
phosphorylation in either S6K Thr389 or 4EBP1 Thr37/46 is
sufficient to indicate that the raptor knockdown RNAi is
effective. During neuronal differentiation, EBs formed from
raptor-knockdown mESCs were smaller than those formed
from luciferase- or rictor-knockdown mESCs (Fig. 3B). EB
size was quantitated by integrating the area of images using
Image Pro Plus. As shown in Fig. 3C, after six days, rictor
RNAi also decreased EB size, although not to the same extent
as raptor RNAi. This EB growth was similar to that in raptor
gene-trap mESCs and also resulted in unsuccessful differen-
tiation. Overall, this result confirmed that both raptor and
rictor RNAi exhibited efficient target-specificity and are
functional; it also indicated that both mTORC1 and mTORC2
may play a role in EB formation.
The decreased EB size formed from raptor gene-trap
mESCs and raptor-knockdown mESCs may result from an
imbalance between cell growth and/or cell death. To
investigate this possibility, we examined S6K, 4EBP1 and
caspase 3, which are related to cell growth and death,
respectively (Fingar et al., 2002; Scott et al., 2007; Shima et
al., 1998). We found that phosphorylation of S6K, but not4EBP1 or cleaved caspase-3, is altered in EBs derived
from raptor-knockdown mESCs during the formation of
EBs (Fig. 3D). The results shown in Fig. 3E indicate that
phosphorylation of S6K was significantly decreased in raptor
knockdown EBs in comparison with the control at all time
points examined. Conversely, although there was a slightly
increased tendency for cleaved caspase-3 over the period of
2 to 6 days in the control luciferase RNAi group, there was
no change in cleaved caspase 3 in EBs derived from raptor
knockdown mESCs when compared to the luciferase knock-
down group. These results may partially explain why the EBs
are smaller in the raptor gene knockdown mESCs.Rapamycin impaired neuronal differentiation ofmESCs
and/or impeded neuronal maturation at day 3, which
may be associated with caspase and S6K activation,
but not 4EBP1
Next, we studied the role of raptor/mTORC1 in the neurons
differentiated from wild-type mESCs. Neuronal precursors
trypsinized from EBs and plated on a culture matrix were
Figure 2 Raptor gene trap homozygote mESC clones form smaller embryoid bodies (EBs). A. The heterozygous raptor gene trap
mESC clone (RRO611) purchased from the International Gene Trap Consortium was subjected to treatment with 1.75–2.25 mg/ml of
geneticin for selection. A few surviving clones were chosen to be further characterized by three-primer PCR analysis. The
three-primer PCR product and Southern blot analysis of heterozygote clones were around 800/1400 base pairs of DNA fragments and
6200/4500 base pairs, respectively. B. Thirty-five micrograms per lane of protein from each clone was analyzed by blotting with
anti-raptor and anti-mTOR antibodies. Actin was used as the loading control, along with inclusion of HEK293T as an additional control.
As 50 μg/lanes was used, the trace of raptor signals appeared in the raptor gene trapped clones on the western blots (bottom panel).
C. We used inverted phase microscopy to record the morphology of EB formation from wild-type and raptor gene trap homozygote
clone #46 mESCs on days 2 and 8. Scale bar, 100 μm. D. Alteration of signaling molecules responding to IGF-1 stimulation as indicated
was examined in control and a raptor gene trapped clone, with serum or after serum starvation, at different points in time. These
blots are representative of one experiment that was repeated three times.
1122 J.-H. Chuang et al.immediately treated with rapamycin (a TORC1 inhibitor) or
wortmannin (a PI3K inhibitor). At 24 h, neurites of mESC-
derived neurons treated with 1 μM rapamycin had spread out
to a density similar to that of the control group (Fig. 4A); but
at 72 h, neurite loss and soma shrinkage had begun to
appear. This observation could also be interpreted to imply
that rapamycin induces neurite retraction so as to delay
neuronal maturation. The same phenomenon was observed
when 0.2 μM rapamycin was used (data not shown). Neurite
length divided by neuronal cell number is plotted in Fig. 4B.
The effect of rapamycin treatment on this parameter was
significant at 72 h after plating. After inhibitors treatment
for 60 h, the effects on the corresponding downstream
signaling molecules were examined (Fig. 4C). Rapamycintreatment only resulted in a decrease in phosphorylation of
S6K Thr389, whereas wortmannin treatment decreased the
phosphorylation of S6K Thr389, Akt Thr308, and Akt Ser473.
The phosphorylation of 4EBP1 Thr37/46 at this point was not
examined as decreased phosphorylation of either S6K Thr389
or 4EBP1 Thr37/46 is sufficient to examine whether the
rapamycin treatment is effective. It is worth noting that
1 μM wortmannin significantly impeded neurite growth from
the start of treatment (Fig. 4B, column 3).
Rapamycin and its analogs, such as CCI-779, activate
autophagy via inhibition of mTOR both in vitro and in vivo
(Ravikumar et al., 2004). Induction of autophagy eventu-
ally results in cell survival, or caspase activation to induce
apoptosis (Scott et al., 2007). To investigate whether
Figure 3 Knockdown of raptor in mESCs retards EB formation and results in unsuccessful neuronal differentiation. A. mESCs were
infected with viruses containing RNAi of luciferase, raptor, or rictor followed by puromycin selection. Western blot analysis was
performed on cell lysates to detect the corresponding proteins and related signaling molecules. These blots are representative of one
experiment that was repeated four times. B. Puromycin-selected mESCs containing raptor knockdown clones were cultivated and
began to form EBs. The morphology of EBs on days 2, 4, and 6 was recorded by inverted phase microscopy. For comparison and clarity
of various EBs sizes and shapes, local and magnified morphologies are shown. This set of images is representative of experiments that
were repeated four times. Scale bar, 100 μm. C. EB size was quantitated by integrating the cross-area of images using Image Pro Plus
software. The images were usually taken from three different fields in each experiment which was repeated three to four times. Each
image typically contains around 10–20 EBs counted so that a total of around 100–200 EBs were evaluated. The y-axis is the mean cell
dimension, and the x-axis is the timing of different treatments. Data are shown as the mean ± S.E. *P b 0.05. D. The lysate from each
mESCs group derived EBs at days 2, 4, and 6 was collected and run onto SDS-PAGE. These samples were further processed by Western
blot analyses to detect proteins as indicated. These blots are representative of an experiment that was repeated three times.
E. Quantitation of cleaved caspase-3, phospho-S6K, phospho-4EBP1, and raptor abundance were respectively normalized to the
individual control which is luciferase RNAi at day 2. Data are shown as the mean ± S.E. (n = 3). *P b 0.05.
1123Raptor in neurons derived from mESCsapoptosis could be one of the mechanisms of neuron/
neurite loss after rapamycin treatment, we examined
caspase 3, a protein that functions in the convergence of
apoptotic cascades. Promotion of caspase-3 cleavage in
rapamycin-treated neurons began to appear at 24 h after
plating cells on culture plates, and had become more
dramatic by 72 h (Fig. 4D). Interestingly, phosphorylation
of S6K Thr 389 was almost completely inhibited by
rapamycin treatment at 24 h and inhibition persisted up
to 72 h, while phosphorylation of 4EBP1 Thr37/46 showed
no change over the period of rapamycin treatment. Mouse
C2C12 cell lysates treated with TNF-α plus cyclohexamide
(CHX) or with insulin were also included to verify the
efficacy of the antibodies. Quantitated results are shown in
Fig. 4E. Cleaved caspase 3 was significantly increased at
the time points analyzed. In summary, rapamycin treat-
ment significantly decreased the phosphorylation of S6KThr 389, but did not change the phosphorylation of 4EBP1
Thr37/46 over time.Raptor knockdown after neuronal differentiation of
wild-type mESCs impeded growth of neurites
We further explored the role of raptor in the neuronal
differentiation of wild-type mESCs. After differentiation of
mESCs for three days, neurons were infected with raptor
RNAi, control luciferase RNAi or received no treatment.
Three days after virus infection, neuron/neurite length was
very similar among the various groups as shown by type III
β-tubulin staining (Fig. 5A). However, neurite networks with
raptor RNAi infection began to appear severely discontinu-
ous and fibrous on day 6 or 7 after virus infection, a
phenomenon not seen in the control RNAi group or group
Figure 4 mTORC1/rapamycin regulates neuronal differentiation and neurite growth in neurons derived from mESCs. A. Neuronal
precursors dissociated from EBs were plated onto culture dishes and immediately treated with 1 μM rapamycin or 1 μM wortmannin
for 72 h continuously. A set of representative pictures taken in a phase-contrast field shows the neuronal networks. Scale bar, 40 μm.
B. Images were analyzed by Image Pro Plus software. The images were usually taken from three different fields in each experiment,
which was repeated three to four times. Each image typically contained more than the 50 neurons, so that in total around 500 neurons
were evaluated. The y-axis is the ratio of neurite length to cell number, and the x-axis is the timing of drug treatment. Data are
shown as the mean ± S.E. *P b 0.05. C. After treatment with the indicated drugs for 60 h, we analyzed the phosphorylated and total
amount of related proteins using western blotting. β-Actin was used as a loading control. These blots are representative of one
experiment that was repeated three times. D. Neuronal precursors dissociated from EBs were treated with 1 μM rapamycin for 24, 48,
or 72 h. Cell lysates were immunoblotted with different antibodies as indicated. C2C12 myoblasts treated with or without 60 μM
cyclohexamide (CHX) for 6 h followed by tumor necrosis factor (TNF)-α stimulation and with 100 nM insulin were used as positive
controls for antibodies of caspase-3 and phosphorylated S6K and 4EBP1 (lanes 7, 8, and 9), respectively. β-Actin was used as a loading
control. These blots are representative of one experiment that was repeated five times. E. Quantitation of cleaved caspase-3/
phospho-S6K/phospho-4EBP1 was respectively normalized to the individual control with no treatment at 24 h (lane 1). Data are
shown as the mean ± S.E. (n = 5). *P b 0.05.
1124 J.-H. Chuang et al.with no RNAi. On day 7 (i.e., 10 days after plating), some
neurons in all the groups developed varicosity, including
those treated with raptor RNAi, control RNAi, and even in
the group with no RNAi. However, only neurites in the raptor
RNAi treatment group developed severe discontinuity and
fibrous morphological appearance, whereas there was not
much difference between the varicosity in the control RNAi
or no RNAi groups. This result suggests that the change in
appearance in the neurons was not due to virus infection,
but to the loss of function of raptor. The ratio of neurite
length to number of cells is shown in Fig. 5B. This parameter
was significantly decreased at seven days after raptor RNAi
infection. Protein abundance of raptor and its signaling
molecules respectively corresponding to the efficacy of
RNAi and its subsequent function on day 6 after virus
infection are shown in Fig. 5C. At six days post raptorRNAi viral infection, phosphorylation of S6K Thr389 was
decreased, whereas phosphorylation of 4EBP1Thr37 was
unchanged (Fig. 5D). These results indicate that mTORC1
downstream molecules could function differently in neurite
survival/network maintenance in glutamatergic neurons
differentiated from mESCs.Overexpression of S6K T389E prevents
rapamycin-induced neuron/neurite loss
In order to further investigate the role played by raptor/
mTORC1/S6K in the neuronal differentiation of mESCs, we
next constructed a vector that functionally mimics active
S6K and overexpresses in mESCs. To test if this plasmid is
functional, the lentiviral backbone vector encoding green
Figure 5 Knockdown of raptor in neurons differentiated from wild-type mESCs impedes morphology of neurites. A. Viral particles
containing raptor or luciferase RNAi began to infect neurons when they were differentiated from wild-type mESCs for three days. A
set of neurons derived from wild-type mESCs with no RNAi infection was also included for comparison. Cultures were observed for 10
more days. These samples were fixed and immunocytochemistry was performed with class III β-tubulin (green) as the primary
antibodies and Alexa 488-conjugated anti-rabbit IgG as the secondary antibodies. The same field was stained with DAPI. Images shown
here are representative of days 3 and 7 after RNAi infection. Local and magnified morphologies are shown. White arrows
representatively indicate some discontinuous neurites. Scale bar, 20 μm. B. The ratio of neurites to number of cells was analyzed by
MetaMorph software. The images were usually taken from three different fields in each experiment, which was repeated three to four
times. More than the 50 neurons were typically counted in each image, so that a total of around 500 neurons were evaluated in all.
The y-axis is the ratio, and the x-axis is the time of infection. Data are shown as the mean ± S.E. *P b 0.05. C. Neurons were harvested
six days after viral infection with raptor or luciferase, or after no viral infection, and subjected to a western blot analysis. Cell lysates
were immunoblotted with different antibodies as indicated. These blots are representative of one experiment that was repeated
three times. D. Phosphorylation of S6K Thr389 and 4EBP1 Thr37, and raptor abundance were quantitated using the freeware, NIH
Image J. Quantitation was respectively normalized to the individual control with no RNAi treatment. Data are shown as the mean ±
S.E. (n = 3). *P b 0.05.
1125Raptor in neurons derived from mESCsfluorescent protein (GFP) tagged S6K T389E and driven by
the CMV promoter was transfected into HEK293T cells
(Fig. 6A). Cells transfected with GFP alone or S6K wild type
constructed in the same lentiviral backbone were used as
controls. The cells containing S6K T389E could still resist
the inhibition of mTORC1 by rapamycin as evidenced by
sustained S6 phosphorylation, an indicator of S6K activation.
As viral particle-containing constructs were used to infect
mESCs and puromycin selection was performed, the cells
that expressed the relevant proteins were confirmed by the
GFP images and S6K antibody blotting (Fig. 6B). When these
mESCs began to differentiate into neurons, they were also
treated with 1 μM rapamycin. The difference in neuron/neurite morphology became obvious at day 4 after plating.
As shown in Fig. 6C, rapamycin treatment resulted in a
neuronal loss in S6K wild type or control group. However, the
neuronal loss caused by rapamycin was prevented by S6K
T389E overexpression. Initially, we also performed rescue
experiments by which the wild-type mESC-derived neurons
were infected with the abovementioned constructs at 12 h
after rapamycin treatment. The results showed that the
neurons almost completely die within 3–4 days in all groups
except those overexpressing S6K T389E (data not shown).
However, because so few cell lysates could be collected to
clearly demonstrate the expression of relevant proteins, we
adopted the strategy of overexpressing abovementioned
Figure 6 Raptor/S6K signaling pathway plays a crucial role in neuronal differentiation of mESCs. A. HEK293T cells were transiently
transfected with constructs modified from pLKO.1, a lentivirus backbone that overexpress GFP tagged proteins. Cells were treated
with 0.2 μM rapamycin for various time periods. Cell lysates were processed for western blot analysis to detect the corresponding
proteins and phosphorylation of S6 S235/236, direct downstream phosphorylation sites of activated S6K. These blots are
representative of one experiment that was repeated three times. B. These constructs were packed within viral particles and used to
infect mESCs. mESCs infected with the indicated plasmids were examined the infection using fluorescent microscopy (green). The
expression level of S6K protein was analyzed using Western blot. The same field was stained with DAPI (blue). Scale bar, 20 μm. C.
mESCs containing the indicated constructs began to differentiate into neurons. These neuron precursors were subjected to 1 μM
rapamycin treatment immediately after plating. At day 4 after plating, a difference was observed between neurons containing S6K
T389E and the controls. These samples were fixed and immunocytochemistry was performed with class III β-tubulin (red) as the
primary antibodies and DyLight 549-conjugated anti-rabbit IgG as the secondary antibodies. The same field was stained with DAPI
(blue). Local and magnified morphologies are shown. Scale bar, 20 μm. D. The ratio of neurites to number of cells was analyzed by
MetaMorph software. The images were usually taken from three different fields in each experiment, which was repeated three to four
times. Each image typically contained more than the 50 neurons, so that in total around 500 neurons were evaluated. The y-axis is the
ratio, and the x-axis is the time of infection. Data are shown as the mean ± S.E. *P b 0.05.
1126 J.-H. Chuang et al.constructs before rapamycin treatment to show the role of
S6K in neurons derived from mESCs. Neurite length divided
by neuronal cell number was significantly decreased in
cells overexpressing GFP or GFP S6K wild type treated by
rapamycin in comparison with the ones treated by DMSO
(Fig. 6D). The parameter was slightly decreased in the group
of cells overexpressing GFP S6K T389E. However, loss of
neurite density resulting from rapamycin treatment in cells
overexpressing GFP or GFP S6K wild type could be greatly
prevented by overexpression of S6K T389E. Together, theresults suggest that the raptor/S6K signaling pathway
mediates the neuronal differentiation of mESCs.Discussion
The central finding of this study is that raptor/S6K is critical
in neurogenesis of mESCs, as measured in a predominantly
glutamatergic population. We also found that S6K, but not
4EBP, correlates with this process. Furthermore, the role of
1127Raptor in neurons derived from mESCsS6K in the morphological change of neurons/neurites may
also be time dependent.
An interesting discovery was that mTORC1 did not affect
neurite density, as measured by neurite length divided by
number of neurons, in the initial period in neuronal differen-
tiation. Considering that the number of neurons did not change
over time but the neurons shrank in size in rapamycin-treated
mESCs, the decreased parameter observed at 48–72 h could be
primarily due to the loss of neurite length. It thus can be
inferred that rapamycin did not destroy the distribution of
neurites, as S6K Thr389 had already significantly decreased at
24 h after EB dissociation (Fig. 4). This phenomenon seems to
differ from many cell types such as HEK 293T, HeLa, and MEF
cells, in which cell death occurs a few hours after treatment
with high concentrations of rapamycin. Similarly, the neurite
network was significantly disrupted within 24–72 h of treat-
ment with wortmannin. Differences in the effects of rapamycin
and wortmannin may simply be attributed to different
efficacies of the drugs or dosages. Furthermore, comparing
morphological and signal differences between rapamycin and
wortmannin treatment, phosphorylated Akt might also play a
role in neurite outgrowth. Nevertheless, raptor/mTORC1 might
be a specific regulator by which neuronal differentiation may
become more mTORC1-dependent after differentiation for 48–
72 h. The time-dependence of the importance of S6K and
rapamycin in development of neurons in vivo has been reported.
During differentiation of extending neural processes inmice and
Drosophila, S6K was reported to play an increasingly important
role in the increase in cell size (Bateman and McNeill, 2004;
Shima et al., 1998; Zhang et al., 2000). Hence, we suggest that
neurons derived from mESCs rely on raptor/mTORC1, and this
process may be development dependent.
Another interesting observation is that phosphorylation of
S6K, but not 4EBP1, was decreased in rapamycin- or raptor
RNAi-treated neurons derived from mESCs, and this decrease
was associated with the loss of neurons/neurites. Both S6K and
4EBP are direct downstream molecules of mTORC1, but their
differing functions in in vivo systems of cell differentiation have
been reported. In undifferentiated photoreceptor cells of the
ommatidia in Drosophila, mutation of TSC leads to a profound
impairment in the timing of differentiation in these cell
clusters. S6K, but not 4EB-P1, found to act downstream of
TORC1 in this pathway (McNeill et al., 2008). Furthermore,
Mainwaring and Kenny demonstrated a novel mechanism
whereby eIF4E and S6K are differentially regulated in prolifer-
ating cerebellar neural precursors by SHH (Mainwaring and
Kenney, 2011). Therefore, the observation of a difference
between S6K and 4EBP1 phosphorylation in neurons either in
vivo or in vitro such as in our mESC-derived neuronal model
implies that additional regulation might be involved.
The homozygote raptor gene trap clones verified by PCR
and Southern blot analysis demonstrated that the gene is
indeed being “trapped,” so that no proteins are expressed.
Despite the genotype, the faint raptor band seen in the
western blot, as well as subsequent immunoprecipitation
for MS-SPEC analysis (data not shown), precludes us from
claiming that these clones are knockouts. Since the intron-
trapping vector contained a splice acceptor, it is highly
possible that these clones developed a “leak” in the gene-
trap approach due to a skip in splicing. Even a low level of
raptor expression resulting either from the gene trap or RNAi
knockdown caused a decrease in EB size, which mightsubsequently result in the failure of neuronal differentia-
tion. Raptor knockout mice die early in development
(Guertin et al., 2006). Nevertheless, Drosophila mutants or
mice containing inactivated S6K, one of mTORC1 direct
substrates, survived development and exhibited a normal
body shape, but a 50% decrease overall in body size due
entirely to a decrease in cell size, while the overall number
of cells was unaltered (Montagne et al., 1999; Shima et al.,
1998). The differences caused by raptor and its downstream
effector S6K on development suggest that raptor could have
a broader effect on biological function, in addition to cell
growth/size.
In conclusion, in this study we differentiated mESCs into
almost completely uniform glutamatergic neurons and
demonstrated that loss-of-function of raptor/mTORC1 im-
peded their neurogenesis from mESCs. Equally important, a
difference between the activation of mTORC1 downstream
molecules S6K and 4EBP1 was observed during the differen-
tiation of glutamatergic neurons from mESCs. Considering
the importance of mTORC1 in cell growth, neurogenesis from
mESCs in addition to measuring predominantly glutamatergic
neurons like our model could also require mTORC1/raptor/
S6K signaling.
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